Disease Markers

High-Throughput Screening for Biomarker Discovery


Status
Published

1Mahidol University, Bangkok, Thailand

2Yamaguchi University, Yamaguchi, Japan

3Cornell University, New York, USA

4National Cheng Kung University, Tainan, Taiwan


High-Throughput Screening for Biomarker Discovery

Description

Biomarkers are indicators of disease occurrence and progression. They can be used to assess normal biological and pathogenic processes, or pharmacologic responses to a therapeutic intervention, and in some cases they may serve as potential drugs and prognostic targets. In the postgenomic era, the omics techniques have been applied and served as high-throughput screening for identification of potential biomarkers for pathogenesis of several diseases including cancer, genetic diseases, metabolic diseases, and infectious diseases. These biomarkers would lead to the understanding of the mechanism of pathogenesis and might be clinically useful as the molecular targets for better diagnosis, prognosis, and treatment.

We invite investigators to contribute original research articles as well as review articles that will stimulate the continuing efforts in the field of high-throughput screening of molecular biomarkers. We are particularly interested in articles describing the new technologies for biomarker discovery; advances in molecular genetics, epigenetics, and molecular diagnostics; new insights and current concepts on omics; the application and validation of biomarkers identified through the high-throughput screening.

Potential topics include, but are not limited to:

  • Recent development in high-throughput screening of biomarkers
  • Omics identification of molecular biomarkers including genomics, transcriptomics, proteomics, metabolomics, and other relevant aspects
  • Omics-based discovery of pathogen biomarkers as drug targets and diagnostic assays
  • High-throughput identification of biomarkers for pathogenesis
  • Potential use of biomarkers from high-throughput methods for diagnosis, prognosis, and therapeutic purposes
  • Quality control and validation of biomarkers from high-throughput screening

Articles

  • Special Issue
  • - Volume 2015
  • - Article ID 105358
  • - Research Article

Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach

Tavan Janvilisri | Kawin Leelawat | ... | Rutaiwan Tohtong
  • Special Issue
  • - Volume 2015
  • - Article ID 108064
  • - Editorial

High-Throughput Screening for Biomarker Discovery

Tavan Janvilisri | Haruo Suzuki | ... | Varodom Charoensawan
  • Special Issue
  • - Volume 2015
  • - Article ID 762128
  • - Review Article

Omics-Based Identification of Biomarkers for Nasopharyngeal Carcinoma

Tavan Janvilisri
  • Special Issue
  • - Volume 2015
  • - Article ID 321370
  • - Review Article

Proteomics in Cancer Biomarkers Discovery: Challenges and Applications

Reem M. Sallam
  • Special Issue
  • - Volume 2015
  • - Article ID 351015
  • - Research Article

Analysis of Serum MicroRNAs as Potential Biomarker in Coronary Bifurcation Lesion

Yan Liu | Shaoliang Chen | ... | Tian Xu
  • Special Issue
  • - Volume 2015
  • - Article ID 629367
  • - Research Article

Comparative Proteomic Analysis of Human Cholangiocarcinoma Cell Lines: S100A2 as a Potential Candidate Protein Inducer of Invasion

Kasima Wasuworawong | Sittiruk Roytrakul | ... | Waraporn Komyod
  • Special Issue
  • - Volume 2015
  • - Article ID 824304
  • - Research Article

Polymorphisms in C-Reactive Protein and Glypican-5 Are Associated with Lung Cancer Risk and Gartrokine-1 Influences Cisplatin-Based Chemotherapy Response in a Chinese Han Population

Shuo Zhang | Asmitananda Thakur | ... | Mingwei Chen
Disease Markers
 Journal metrics
Acceptance rate34%
Submission to final decision88 days
Acceptance to publication43 days
CiteScore3.500
Impact Factor2.738
 Submit